Showing results (21-30 of 315) with videos related to
Sort By:
Pageof 32
World Journal of Urology|November 26, 2011
Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrastsKyle O Rove, E David CrawfordThe Canadian Journal of Urology|April 26, 2020
The role of FSH and LH in prostate cancer and cardiometabolic comorbiditiesE David Crawford, Andrew V SchallyOncology (Williston Park, N.Y.)|April 16, 2008
Emerging role of HIFU as a noninvasive ablative method to treat localized prostate cancerAl B Barqawi, E David CrawfordTargeted Oncology|June 17, 2017
Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There YetDaniel P Petrylak, E David CrawfordThe Canadian Journal of Urology|April 30, 2014
Traditional androgen ablation approaches to advanced prostate cancer: new insightsKyle O Rove, E David CrawfordOncology (Williston Park, N.Y.)|February 15, 2012
Evolution of treatment options for patients with CRPC and bone metastases: bone-targeted agents that go beyond palliation of symptoms to improve overall survivalKyle O Rove, E David CrawfordOncology (Williston Park, N.Y.)|March 8, 2012
Optimizing outcomes of advanced prostate cancer: drug sequencing and novel therapeutic approachesE David Crawford, Thomas W FlaigThe Urologic Clinics of North America|May 5, 2004
Screening for prostate cancer: current recommendationsShandra S Wilson, E David CrawfordClinical Prostate Cancer|July 29, 2004
Screening for prostate cancerShandra S Wilson, E David CrawfordReviews in Urology|April 30, 2010
Intermittent androgen deprivation therapy: redefining the standard of care?Neal D Shore, E David CrawfordPageof 32